14168EGP
- Active ingredient
- eribulin
- Strength
- 1mg/2ml
- Form
- vial
- Manufacturer
- eisai > multipharma
- Route
- injection
Uses
Used for metastatic breast cancer and certain advanced liposarcomas after prior chemotherapy.
Do not use if
No specific contraindications are established other than hypersensitivity.
Side effects
Neutropenia, fatigue, alopecia, peripheral neuropathy, nausea, and constipation may occur.
Warnings
Monitor blood counts and signs of peripheral neuropathy.
How it works
Microtubule inhibitor that disrupts mitosis and promotes cancer cell death.
Storage
Store according to product labeling and protect from inappropriate temperatures.